Azilsartan Medoxomil Potassium

美阿沙坦钾

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAzilsartan Medoxomil Potassium
Drug Alias Name阿齐沙坦美多酯azilsartanum medoxomilum美阿沙坦Azilsartan Kamedoxomil阿齐沙坦酯钾 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsEssential HypertensionHypertension
Approved Indications in ChinaEssential Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date2011/02/25
Country/TerritoryBulgariaUnited StatesSlovakia +[26] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverest Medicines (China) Co LtdEverest Medicines LtdTakeda Pharmaceutical Co Ltd +[6] 
Inactive CompaniesAnderson Packaging IncAndersonbrecon IncTakeda Canada Inc +[4] 
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09CA09
Related LinksWikipediaDrugBankKEGG